Murine models of asthma in understanding immune dysregulation in human asthma
- 1 July 2000
- journal article
- review article
- Published by Elsevier in Immunopharmacology
- Vol. 48 (3) , 263-268
- https://doi.org/10.1016/s0162-3109(00)00223-x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Chemokine production by human vascular smooth muscle cells: modulation by IL‐13British Journal of Pharmacology, 1997
- IL‐13 production by allergen‐stimulated T cells is increased in allergic disease and associated with IL‐5 but not IFN‐γ expressionImmunology, 1997
- Interleukin-13 but Not Interleukin-4 Prolongs Eosinophil Survival and Induces Eosinophil Chemotaxis.Internal Medicine, 1997
- Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors.Journal of Clinical Investigation, 1996
- Cloning and Characterization of a Specific Interleukin (IL)-13 Binding Protein Structurally Related to the IL-5 Receptor α ChainJournal of Biological Chemistry, 1996
- Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.The Journal of Experimental Medicine, 1996
- Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.The Journal of Experimental Medicine, 1995
- Effects of interleukin (IL)‐13 on immediate‐early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL‐4European Journal of Immunology, 1995
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- Recombinant human interleukin 5 is a selective eosinophil chemoattractantEuropean Journal of Immunology, 1989